Understanding, predicting and achieving liver transplant tolerance: from bench to bedside

Area of Science:

• Immunology
• Transplantation Medicine
• Hepatology

Background:

• Liver transplantation has advanced significantly over 40 years, improving patient and graft survival.
• The liver's unique immune properties can promote tolerance, allowing some recipients to withdraw immunosuppression.
• Chronic allograft injury and immunosuppression side effects remain challenges in liver transplantation.

Purpose of the Study:

• To review advancements in understanding liver transplant tolerance.
• To discuss mechanisms promoting donor-specific tolerance in the liver.
• To explore novel therapeutic targets and biomarkers for liver transplant recipients.

Main Methods:

• Review of current literature on liver transplantation and immunology.
• Analysis of mechanisms regulating innate and adaptive immunity in the liver.
• Discussion of strategies for immunosuppressive drug minimization, including cell-based therapies.

Main Results:

• The liver's microenvironment and immune cells play a key role in promoting antigen-specific tolerance.
• Insights into tolerance mechanisms can guide biomarker identification and therapeutic target development.
• Adoptive transfer of regulatory immune cells is a promising approach for promoting tolerance.

Conclusions:

• Understanding liver transplant tolerance mechanisms is crucial for overcoming current obstacles.
• Novel strategies targeting immune regulation hold potential for improving long-term outcomes.
• Further research can lead to reduced immunosuppression and better graft survival in liver transplantation.